FY2024 Earnings Forecast for Stoke Therapeutics, Inc. (NASDAQ:STOK) Issued By Cantor Fitzgerald

Stoke Therapeutics, Inc. (NASDAQ:STOK – Free Report) – Equities researchers at Cantor Fitzgerald issued their FY2024 earnings per share (EPS) estimates for shares of Stoke Therapeutics in a note issued to investors on Tuesday, July 11th. Cantor Fitzgerald analyst C. Duncan expects that the company will earn ($2.34) per share for the year. The consensus […]

Related Keywords

Hong Kong ,United States ,America ,American ,Barry Ticho ,Jonathan Allan ,Great West Life Assurance Co ,American International Group Inc ,York Mellon Corp ,Securities Exchange Commission ,Stoke Therapeutics Company Profile ,Cantor Fitzgerald ,Stoke Therapeutics Inc ,Hong Kong Ltd ,Needham Company ,Canaccord Genuity Group ,Nasdaq ,Ensign Peak Advisors Inc ,Stoke Therapeutics ,Free Report ,Stoke Therapeutic ,Get Free Report ,Exchange Commission ,General Counsel Jonathan Allan ,New York Mellon Corp ,International Group ,West Life Assurance ,Peak Advisors Inc ,Kong Ltd ,Stoke Therapeutics Daily ,Nasdaq Stok ,Istok ,Medical ,Earnings Estimates ,